Disease Comparison

Compare similarities and differences between two diseases.

Bladder Cancer

Unknown
4
Symptoms
3
Causes
0
Treatments
5
FAQs
VS

Hepatitis C

Unknown
3
Symptoms
1
Causes
0
Treatments
5
FAQs

Overview

Bladder Cancer
Bladder cancer is a malignant growth that develops from cells lining the urinary bladder. The most common warning sign is blood in the urine, which may be visible or detected only by testing. Some people may also experience increased urinary frequency, urgency, burning, or discomfort. Bladder cancer can remain limited to the inner layers of the bladder or grow deeper into the bladder wall and surrounding tissues. Early evaluation of unexplained urinary bleeding is important because the disease may be easier to treat when detected earlier.
Hepatitis C
Hepatitis C is a liver infection caused by the hepatitis C virus. It is transmitted primarily through contact with infected blood. Many people have few or no symptoms at first, but persistent infection can cause liver inflammation and, over time, serious complications such as cirrhosis or liver cancer. Acute hepatitis C may cause fatigue, nausea, abdominal discomfort, dark urine, or yellowing of the skin and eyes, although many people have no obvious symptoms. Some infections clear without treatment, while others become chronic. Chronic hepatitis C can progressively damage the liver if it remains untreated.

Symptoms

Shared
Weight Loss
Only in Left Disease
Cloudy Urine Persistent Hoarseness Urgent Urination
Only in Right Disease
Blood In Stool Fatigue

Causes

Shared
None
Only in Left Disease
High Cholesterol Insulin Resistance Smoking
Only in Right Disease
Infection

Diagnosis

Bladder Cancer
Evaluation of suspected bladder cancer may include urinalysis and other urine-based tests, imaging of the urinary tract, and cystoscopy, in which the inside of the bladder is examined with a small camera. If a suspicious area is identified, tissue obtained during cystoscopy is examined by a pathologist to establish whether cancer is present and to determine its characteristics. Additional imaging may be used to assess the bladder wall, nearby structures, lymph nodes, or distant areas when more advanced disease is suspected.
Hepatitis C
Hepatitis C is diagnosed with blood tests. An antibody test can show whether a person has been exposed to the virus, while an HCV RNA test confirms whether active infection is present. Additional blood tests and liver assessment help evaluate liver health and the extent of disease. Testing generally begins with an HCV antibody blood test. If antibodies are detected, an HCV RNA test determines whether the virus is currently present. Further assessment may include liver enzyme tests, blood counts, fibrosis assessment, and imaging or other investigations when needed to evaluate liver damage and complications.

Prevention

Bladder Cancer
Avoiding tobacco is one of the most important preventable measures for reducing bladder cancer risk. People who work with chemicals associated with bladder cancer should follow workplace exposure controls and use appropriate protective equipment. Adequate hydration may support normal urinary health, although it does not eliminate cancer risk. Persistent or unexplained blood in the urine should be evaluated promptly, even when it occurs without pain, because early investigation can help identify bladder disease at an earlier stage.
Hepatitis C
Hepatitis C can be prevented by avoiding contact with infected blood. Do not share needles, syringes, razors, or other items that may contain blood. Use properly sterilized medical and tattoo equipment and follow appropriate precautions when there is a risk of blood exposure. There is currently no widely available vaccine for hepatitis C. Prevention therefore depends on reducing blood exposure, using sterile injection and medical equipment, and ensuring appropriate infection-control practices. People with ongoing exposure risks should discuss testing and prevention strategies with a healthcare professional.

Risk Factors

Bladder Cancer
Important risk factors include cigarette smoking, increasing age, certain occupational exposures to chemicals, previous pelvic radiation, exposure to some chemotherapy medicines, chronic bladder irritation, and certain inherited conditions. A history of bladder cancer also increases the likelihood of recurrence. Long-term exposure to some workplace chemicals may be relevant in occupations involving dyes, rubber, leather, textiles, paints, or related industrial materials.
Hepatitis C
Risk factors include sharing needles or other injection equipment, receiving medical care with inadequately sterilized equipment, having a blood transfusion or organ transplant before modern screening was introduced, and other exposures to infected blood. Risk can also increase with certain sexual or occupational exposures. People who inject drugs or share injection equipment have an important risk of blood exposure. Other risks include accidental exposure to infected blood, nonsterile tattooing or piercing equipment, and certain healthcare exposures. People with previous transfusions or transplants before routine HCV screening may also have increased risk.

Treatment

Bladder Cancer
Treatment comparison will be available soon.
Hepatitis C
Treatment comparison will be available soon.